Find uplifting stories about heroes, innovations, and solutions
203 results for "insulin"
California just became the first state to manufacture its own affordable insulin, offering hope to people priced out of lifesaving medication. The CalRx program stocks pharmacies with insulin priced far below commercial brands.
Four senators from both parties are pushing legislation to cap insulin costs at $35 per month for millions of Americans with private insurance. The bill also includes a pilot program to help uninsured patients access affordable insulin.
A groundbreaking FDA-approved treatment is helping Type 1 diabetes patients stop daily insulin injections by replacing their destroyed cells with healthy ones from donated organs. University Hospitals in Cleveland is now offering the therapy that freed 70% of trial participants from insulin after just one year.
Researchers have created a groundbreaking pill that could eliminate the need for daily insulin injections for diabetes patients. The innovation promises to transform diabetes management for millions worldwide.
Japanese researchers developed a peptide pill that helps insulin survive digestion and enter the bloodstream, potentially ending daily injections for millions with diabetes. The breakthrough could transform diabetes care worldwide, especially in countries like India where treatment access remains challenging.
Researchers discovered how to prevent the protein misfolding that damages insulin-producing cells in diabetes, opening the door to treatments that address the disease's root cause instead of just managing symptoms.
A new bipartisan bill aims to cap insulin costs at $35 per month for millions with private insurance, building on Medicare protections already in place. The legislation also tackles pharmacy middlemen and aims to boost competition for the life-saving drug. ##
Nearly 5 million Americans with type 2 diabetes are spending less and staying healthier since Medicare capped insulin costs at $35 per month. The policy proves affordable medication saves lives and money.
A new study shows people with type 1 diabetes who switched to a low-fat vegan diet reduced their daily insulin use by nearly 30 percent in just 12 weeks. The breakthrough findings suggest a simple dietary change could help millions manage their condition more effectively.
A 1920s tuberculosis vaccine is helping people with autoimmune diabetes reduce their insulin use in a breakthrough trial. The discovery adds to growing evidence that certain vaccines protect against diseases far beyond their original targets.
Japanese researchers have developed a peptide technology that allows insulin to be taken as a pill instead of an injection, achieving remarkable effectiveness in diabetic mice. This century-old dream could transform diabetes treatment for millions who endure daily needles.
Researchers in Japan have developed an insulin pill that could replace daily injections for millions with diabetes. Early tests in mice showed the oral medication significantly lowered blood sugar with just one dose per day.
A groundbreaking insulin inhaler could soon spare millions of Type 1 diabetes patients from daily injections. The medical breakthrough offers new hope for easier diabetes management.
A landmark settlement with pharmacy giant Express Scripts will force major changes that could save Americans up to $7 billion on insulin costs over the next decade. The Federal Trade Commission says the company artificially inflated prices and blocked access to the lifesaving diabetes medication.
Women with higher insulin at age 47 experience menopause symptoms earlier and longer, a breakthrough study reveals. The discovery opens doors to managing hot flashes through diet and exercise instead of just medication.
Scientists at LSU's Pennington Biomedical Research Center discovered that tiny cellular structures called peroxisomes play a crucial role in keeping insulin healthy and diabetes at bay. This breakthrough could unlock new ways to protect people from diabetes.
Children with Type 1 diabetes now have their first needle-free insulin option after the FDA approved an inhalable treatment. The breakthrough ends the daily requirement of multiple injections for young patients managing this chronic condition.
CVS Caremark has agreed to settle federal charges that it inflated insulin prices, promising changes that could make the lifesaving diabetes medication more affordable. The move follows similar action by another major pharmacy manager, signaling real progress on drug pricing.
Americans with diabetes just got major financial relief. A federal settlement with CVS Caremark will slash inflated insulin prices and could save patients up to $8.5 billion over the next ten years.
A Michigan Supreme Court ruling just gave state investigators the green light to examine whether a major drug maker unfairly raised insulin prices. The decision could mean real answers for families who've struggled to afford life-saving medication.
Showing 20 of 203